{"id":246307,"date":"2012-11-08T01:46:23","date_gmt":"2012-11-08T01:46:23","guid":{"rendered":"http:\/\/www.eugenesis.com\/optim-llc-launches-new-mobile-feesa%e2%80%9e%c2%a2-system\/"},"modified":"2012-11-08T01:46:23","modified_gmt":"2012-11-08T01:46:23","slug":"optim-llc-launches-new-mobile-feesa%c2%a2-system","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/optim-llc-launches-new-mobile-feesa%c2%a2-system.php","title":{"rendered":"Optim LLC Launches New Mobile FEES\u00e2\u201e\u00a2 System"},"content":{"rendered":"<p><p>    STURBRIDGE, Mass.--(BUSINESS WIRE)--  <\/p>\n<p>    Optim LLC, a designer and manufacturer of portable endoscopic    technologies announced the launch of its new Mobile FEES    system. FEES (Flexible Endoscopic Evaluation of Swallowing) is    becoming a growing need for ENT and speech pathology    clinicians. Optims Mobile FEES System allows clinicians to    set-up portable or office based FEES programs within their    practice. The system includes a portable flexible endoscope,    video camera, FDA cleared software, and related accessories all    within a portable case.  <\/p>\n<p>    Turnkey Training Included  <\/p>\n<p>    One of the key features of the new system is the inclusion of    training by qualified clinicians. Optim has engaged SEC Medical    as its exclusive sales and training partner for the product.    SEC is a leader in medical speech pathology, education,    training, and business practices.  <\/p>\n<p>    We are excited to launch Mobile FEES for our customers, who    have expressed interest in expanding into FEES diagnostics,    said Jeff Barrett, CEO of Optim LLC. Our goal is to provide a    complete turnkey product including our portable flexible    nasopharyngoscope, proprietary camera software, clinical    training, and warrantee and support.  <\/p>\n<p>    Optims new Mobile FEES System is a perfect fit for SEC    Medicals offering in speech pathology education, training, and    business practices, said Kay Neilson, Co-Founder of SEC    Medical. The initial feedback from customers to our integrated    product and training approach has been phenomenal.  <\/p>\n<p>    About Optim  <\/p>\n<p>    Optim (www.optimnet.com)    is a designer and manufacturer of specialty endoscopic    technologies for the ENT, allergy and speech pathology markets.    The companys flagship product, the ENTity nasopharygoscope,    uses the companys patented OptiLux LED technology to produce    the highest quality image in the industry, all within a    portable scope with no external light source.  <\/p>\n<p>    About SEC Medical  <\/p>\n<p>    SEC Medical (www.secmedicalspeech.com)    is a leader in the speech pathology training, education, and    business practice consulting. SEC specializes in training for    FEES\/FEESST, laryngeal sensory testing, video stroboscopy,    modified barium swallow studies, and swallowing disorders    programming.  <\/p>\n<\/p>\n<p>Original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/optim-llc-launches-mobile-fees-140800868.html;_ylt=A2KJ3CfVDptQa24An1D_wgt.\" title=\"Optim LLC Launches New Mobile FEES\u00e2\u201e\u00a2 System\">Optim LLC Launches New Mobile FEES\u00e2\u201e\u00a2 System<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> STURBRIDGE, Mass.--(BUSINESS WIRE)-- Optim LLC, a designer and manufacturer of portable endoscopic technologies announced the launch of its new Mobile FEES system. FEES (Flexible Endoscopic Evaluation of Swallowing) is becoming a growing need for ENT and speech pathology clinicians. Optims Mobile FEES System allows clinicians to set-up portable or office based FEES programs within their practice.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/optim-llc-launches-new-mobile-feesa%c2%a2-system.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-246307","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246307"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=246307"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246307\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=246307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=246307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=246307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}